Difference between revisions of "Team:Pasteur Paris/Interlab study"

→ First, we have performed an efficacy assay so as to elucidate the settings and the amount of template required for our quantitative PCR (qPCR). For this, we amplified TyrA gene (a single copy gene) in gDNA (WT strain), and GFP gene in plasmid DNA (GFP in pSB1C3 strain) at different concentrations (dilution series of 1:10). The results show that the qPCR for TyrA was efficient so the parameters can be used; ≈1ng/uL is the amount of template to use.

→ Afterwards, we performed a parallel qPCR of our templates in order to amplify in one plate the amount of gDNA per strain, and in the other plate the amount of pDNA (GFP+) corresponding to each strain. Thanks to this, a ratio of pDNA (GFP+) / gDNA was obtained; it shows the number of pDNA (GFP+) copies per biological clone and strain.

→ Finally, we analyzed the specific fluorescence of each strain and biological clone in function of its growth (latest iGEM data suggest that GFP is expressed differently depending on the growth curve).

→ Thus, qPCR ratio values were used to normalize the data obtained from fluorescence/growth analyzes, with the purpose of examining the promoter strength on expressing the GFP protein in our different biological clones and strains. In fact, the fluorescence obtained on each biological clone over time is divided by its qPCR ratio, in order to set the specific fluorescence value to a single pDNA (GFP+) devise. Therefore, by analyzing the differential of expression between strains and their biological clones, we determined which promoter triggered a higher GFP expression.